Safflower oil body nanoparticles deliver hFGF10 to hair follicles and reduce microinflammation to accelerate hair regeneration in androgenetic alopecia

Int J Pharm. 2022 Mar 25:616:121537. doi: 10.1016/j.ijpharm.2022.121537. Epub 2022 Feb 10.

Abstract

Androgenetic alopecia (AGA) affects physical and mental health with limited therapeutic options. Novel materials and delivery methods have considerable potential to improve the current paradigm of treatment. In this study, we used a novel plant nanoparticle of safflower oil body (SOB) loaded with human fibroblast growth factor 10 (hFGF10) to target hair follicles and accelerate hair regeneration in AGA mice with few adverse effects. Our data revealed that the average particle size of SOB-hFGF10 was 226.73 ± 9.98 nm, with a spherical and uniform structure, and that SOB-hFGF10 was quicker to preferentially penetrate into hair follicles than hFGF2 alone. Using a mouse model of AGA, SOB-hFGF10 was found to significantly improve hair regeneration without any significant toxicity. Furthermore, SOB-hFGF10 inhibited dihydrotestosterone (DHT)-induced TNF-α, IL-1β, and IL-6 overproduction in macrophages in relation to hair follicle microinflammation, thereby enhancing the proliferation of dermal papilla cells. Overall, this study provides an applicable therapeutic method through targeting hair follicles and reducing microinflammation to accelerate hair regeneration in AGA.

Keywords: Androgenetic alopecia; Follicular microinflammation; Follicular penetration; SOB-hFGF10.

MeSH terms

  • Alopecia / drug therapy*
  • Carthamus tinctorius / chemistry
  • Drug Delivery Systems
  • Fibroblast Growth Factor 10* / administration & dosage
  • Fibroblast Growth Factor 10* / therapeutic use
  • Hair / growth & development
  • Hair Follicle / drug effects
  • Humans
  • Nanoparticles*
  • Regeneration
  • Safflower Oil* / chemistry

Substances

  • Fibroblast Growth Factor 10
  • Safflower Oil